Mitchell Oei
Neurology · Augusta, GANPI 1760111744
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by UCB, Inc. at 44.9% of the total. That places this record below the midpoint for neurology clinicians in GA, where the typical reported total is $1,471.
Across 49 payments — averaging $25.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$551
- AstraZeneca$63
- Biogen$53
- Takeda Pharmaceuticals U.S.A., Inc.$53
- Averitas Pharma Inc.$46
- SK Life Science, Inc.$45
- plus $415 from 15 others
What the payments were for
- Food & beverage$1,226100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 21 | $551 |
| AstraZeneca | 3 | $63 |
| Biogen | 2 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| Averitas Pharma Inc. | 1 | $46 |
| SK Life Science, Inc. | 2 | $45 |
| AbbVie | 2 | $45 |
| Alnylam Pharmaceuticals Inc. | 1 | $37 |
| Boston Scientific | 1 | $37 |
| Chiesi USA, Inc. | 2 | $37 |
| Argenx US, Inc. | 1 | $34 |
| Lundbeck LLC | 1 | $32 |
| EMD Serono, Inc. | 1 | $29 |
| Amgen | 1 | $28 |
| Baxter Healthcare | 1 | $24 |
| Immedica Pharma US, Inc. | 1 | $24 |
| Revance Therapeutics, Inc. | 1 | $21 |
| Merz Pharmaceuticals, LLC | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Catalyst Pharmaceuticals, Inc. | 1 | $15 |
| Novartis | 1 | $15 |
How this compares
$1,226 in reported general payments places this provider in the 45th percentile of 506 neurology providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 18 | $244 |
| Atorvastatin Calcium | 23 | $180 |
| Topiramate | 14 | $108 |
Paid to pharmacies, not to this prescriber.
Other neurology in Augusta
- John MorganAugusta$715K
- Alexis ShaeferAugusta$279K
- Kapil SethiAugusta$52K
- Colin McLeodAugusta$49K
- Debra Moore-HillAugusta$48K
- Mitzi WilliamsSmyrna$1.4M
- Joash LazarusAtlanta$1.1M
- Jeffrey EnglishAtlanta$749K
- Frank BerensonAtlanta$527K
- Julio FlaminiAtlanta$501K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.